PRECIGEN, INC. Variable Lease, Cost
PRECIGEN, INC. (PGEN) reported Variable Lease, Cost of $84.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-04
- PRECIGEN, INC. variable lease, cost for the quarter ending 2026-06-30 was $84.00K, a 6.67% decline year-over-year.
- PRECIGEN, INC. variable lease, cost for the quarter ending 2026-03-31 was $97.00K, a 7.78% increase year-over-year.
- PRECIGEN, INC. variable lease, cost for the quarter ending 2025-12-31 was $105.00K, a 14.13% increase year-over-year.
- PRECIGEN, INC. variable lease, cost for the quarter ending 2025-09-30 was $105.00K, a 14.13% increase year-over-year.
- PRECIGEN, INC. variable lease, cost for fiscal 2025 was $390.00K, a 5.98% increase from fiscal 2024.
- PRECIGEN, INC. variable lease, cost for fiscal 2024 was $368.00K, a 4.17% decline from fiscal 2023.
- PRECIGEN, INC. variable lease, cost for fiscal 2023 was $384.00K, a 9.00% decline from fiscal 2022.
- PRECIGEN, INC. variable lease, cost for fiscal 2022 was $422.00K, a 47.25% decline from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 3 month as first filed | Variable Lease, Cost 6 month | Variable Lease, Cost 6 month as first filed | Variable Lease, Cost 9 month | Variable Lease, Cost 9 month as first filed | Variable Lease, Cost 12 month | Variable Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $84.00K 10-Q · filed 2026-08-04 | $181.00K 10-Q · filed 2026-08-04 | $286.00K derived: sum of 3 quarters · filed 2026-08-04 | $391.00K derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $97.00K 10-Q · filed 2026-05-13 | $202.00K derived: sum of 2 quarters · filed 2026-05-13 | $307.00K derived: sum of 3 quarters · filed 2026-05-13 | $397.00K derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $210.00K derived: sum of 2 quarters · filed 2026-03-25 | $300.00K derived: sum of 3 quarters · filed 2026-08-04 | $390.00K 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | $105.00K 10-Q · filed 2025-11-13 | $195.00K derived: sum of 2 quarters · filed 2026-08-04 | $285.00K 10-Q · filed 2025-11-13 | $377.00K derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $90.00K 10-Q · filed 2026-08-04 | $180.00K 10-Q · filed 2026-08-04 | $272.00K derived: sum of 3 quarters · filed 2026-08-04 | $364.00K derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $90.00K 10-Q · filed 2026-05-13 | $182.00K derived: sum of 2 quarters · filed 2026-05-13 | $274.00K derived: sum of 3 quarters · filed 2026-05-13 | $366.00K derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $92.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $184.00K derived: sum of 2 quarters · filed 2026-03-25 | $276.00K derived: sum of 3 quarters · filed 2026-03-25 | $368.00K 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | $92.00K 10-Q · filed 2025-11-13 | $184.00K derived: sum of 2 quarters · filed 2025-11-13 | $276.00K 10-Q · filed 2025-11-13 | $365.00K derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2024-06-30 | $92.00K 10-Q · filed 2025-08-12 | $184.00K 10-Q · filed 2025-08-12 | $273.00K derived: sum of 3 quarters · filed 2026-03-25 | $362.00K derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2024-03-31 | $92.00K 10-Q · filed 2025-05-14 | $181.00K derived: sum of 2 quarters · filed 2026-03-25 | $270.00K derived: sum of 3 quarters · filed 2026-03-25 | $356.00K derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2023-12-31 | $89.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $178.00K derived: sum of 2 quarters · filed 2026-03-25 | $264.00K derived: sum of 3 quarters · filed 2026-03-25 | $384.00K 10-K · filed 2026-03-25 | ||||
| 2023-09-30 | $89.00K 10-Q · filed 2024-11-14 | $175.00K derived: sum of 2 quarters · filed 2024-11-14 | $295.00K 10-Q · filed 2024-11-14 | $409.00K derived: sum of 4 quarters · filed 2025-03-19 | ||||
| 2023-06-30 | $86.00K 10-Q · filed 2024-08-14 | $206.00K 10-Q · filed 2024-08-14 | $320.00K derived: sum of 3 quarters · filed 2025-03-19 | $404.00K derived: sum of 4 quarters · filed 2025-03-19 | ||||
| 2023-03-31 | $120.00K 10-Q · filed 2024-05-14 | $234.00K derived: sum of 2 quarters · filed 2025-03-19 | $318.00K derived: sum of 3 quarters · filed 2025-03-19 | $439.00K derived: sum of 4 quarters · filed 2025-03-19 | ||||
| 2022-12-31 | $114.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $198.00K derived: sum of 2 quarters · filed 2025-03-19 | $319.00K derived: sum of 3 quarters · filed 2025-03-19 | $422.00K 10-K · filed 2025-03-19 | ||||
| 2022-09-30 | $84.00K 10-Q · filed 2023-11-09 | $205.00K derived: sum of 2 quarters · filed 2023-11-09 | $308.00K 10-Q · filed 2023-11-09 | $485.00K derived: sum of 4 quarters · filed 2024-03-19 | ||||
| 2022-06-30 | $121.00K 10-Q · filed 2023-08-09 | $224.00K 10-Q · filed 2023-08-09 | $401.00K derived: sum of 3 quarters · filed 2024-03-19 | $586.00K derived: sum of 4 quarters · filed 2024-03-19 | ||||
| 2022-03-31 | $103.00K 10-Q · filed 2023-05-10 | $117.00K 10-Q · filed 2022-05-09 | $280.00K derived: sum of 2 quarters · filed 2024-03-19 | $465.00K derived: sum of 3 quarters · filed 2024-03-19 | $686.00K derived: sum of 4 quarters · filed 2024-03-19 | |||
| 2021-12-31 | $177.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $362.00K derived: sum of 2 quarters · filed 2024-03-19 | $583.00K derived: sum of 3 quarters · filed 2024-03-19 | $800.00K 10-K · filed 2024-03-19 | $853.00K 10-K · filed 2022-03-01 | |||
| 2021-09-30 | $185.00K 10-Q · filed 2022-11-09 | $199.00K 10-Q · filed 2021-11-08 | $406.00K derived: sum of 2 quarters · filed 2022-11-09 | $623.00K 10-Q · filed 2022-11-09 | $663.00K 10-Q · filed 2021-11-08 | $824.00K derived: sum of 4 quarters · filed 2023-03-06 | ||
| 2021-06-30 | $221.00K 10-Q · filed 2022-08-08 | $234.00K 10-Q · filed 2021-08-09 | $438.00K 10-Q · filed 2022-08-08 | $464.00K 10-Q · filed 2021-08-09 | $639.00K derived: sum of 3 quarters · filed 2023-03-06 | $844.00K derived: sum of 4 quarters · filed 2023-03-06 | ||
| 2021-03-31 | $230.00K 10-Q · filed 2022-05-09 | $418.00K derived: sum of 2 quarters · filed 2023-03-06 | $623.00K derived: sum of 3 quarters · filed 2023-03-06 | $848.00K derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2020-12-31 | $188.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $393.00K derived: sum of 2 quarters · filed 2023-03-06 | $618.00K derived: sum of 3 quarters · filed 2023-03-06 | $842.00K 10-K · filed 2023-03-06 | ||||
| 2020-09-30 | $205.00K 10-Q · filed 2021-11-08 | $474.00K 10-Q · filed 2020-11-09 | $430.00K derived: sum of 2 quarters · filed 2021-11-08 | $654.00K 10-Q · filed 2021-11-08 | $1.51M 10-Q · filed 2020-11-09 | -$142.00K derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-30 | $225.00K 10-Q · filed 2021-08-09 | $544.00K 10-Q · filed 2020-08-10 | $449.00K 10-Q · filed 2021-08-09 | $1.04M 10-Q · filed 2020-08-10 | -$347.00K derived: sum of 3 quarters · filed 2022-03-01 | $272.00K derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-31 | $224.00K 10-Q · filed 2021-05-10 | $493.00K 10-Q · filed 2020-05-11 | -$572.00K derived: sum of 2 quarters · filed 2022-03-01 | $47.00K derived: sum of 3 quarters · filed 2022-03-01 | $555.00K derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | -$796.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$177.00K derived: sum of 2 quarters · filed 2022-03-01 | $331.00K derived: sum of 3 quarters · filed 2022-03-01 | $845.00K 10-K · filed 2022-03-01 | $2.08M 10-K · filed 2020-03-02 | |||
| 2019-09-30 | $619.00K 10-Q · filed 2020-11-09 | $1.13M derived: sum of 2 quarters · filed 2020-11-09 | $1.64M 10-Q · filed 2020-11-09 | |||||
| 2019-06-30 | $508.00K 10-Q · filed 2020-08-10 | $1.02M 10-Q · filed 2020-08-10 | ||||||
| 2019-03-31 | $514.00K 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |